Title
POSSIBLE MUTATION PATHWAYS IN SARS-CoV-2
Date Issued
01 January 2021
Access level
open access
Resource Type
journal article
Author(s)
Islam M.T.
Herrera-Bravo J.
Khan I.N.
Bawazeer S.S.
Kumar M.
Cruz-Martins N.
Martorell M.
Docea A.O.
Sharifi-Rad J.
Daştan S.D.
Drăgănescu D.
Arsene A.L.
Călina D.
Universidad Arturo Prat
Publisher(s)
Romanian Society for Pharmaceutical Sciences
Abstract
Mutations are the best way to generate genetic variation, as they provide the raw material in which evolutionary forces, like natural selection, can act. However, mutations are not always able to change the apparent behaviour of an organism, instead, they are capable of providing normal and abnormal biological functions. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a new and controversial biological scenario. Despite the hundreds of studies performed, to date, there is no specific treatment available. Several genomic and non-genomic mutations have been also reported, and due to its high genome size and mutation capacity, it can acclimatize to variable environments and has become the leading cause of high infection and mortality rates. This review outlines the possible pathways behind SARS-CoV-2 mutations.
Start page
1001
End page
1017
Volume
69
Issue
6
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Epidemiología
Subjects
Scopus EID
2-s2.0-85122081796
Source
Farmacia
ISSN of the container
00148237
Sources of information:
Directorio de Producción Científica
Scopus